Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 220 | 258 | 931 | 1,946 | 3,801 |
| Gross Profit | 220 | 258 | 931 | 1,946 | 3,801 |
| Operating Expenses | 8,061 | 9,420 | 8,413 | 8,350 | 10,763 |
| Operating Income | -7,842 | -9,162 | -7,482 | -6,404 | -6,961 |
| Other Income | -4,474 | 3,255 | 1,083 | -1,332 | 4,083 |
| Pre-tax Income | -12,316 | -5,907 | -6,399 | -7,736 | -2,879 |
| Net Income Continuous | -12,316 | -5,907 | -6,399 | -7,736 | -2,879 |
| Minority Interests | -1,438 | -828 | -1,012 | -545 | -187 |
| Net Income | $-10,878 | $-5,079 | $-5,387 | $-7,192 | $-2,691 |
| EPS Basic Total Ops | -6.00 | -2.80 | -3.00 | -4.60 | -1.60 |
| EPS Basic Continuous Ops | -6.87 | -3.30 | -3.59 | -5.05 | -1.62 |
| EPS Diluted Total Ops | -6.00 | -2.80 | -3.00 | -3.00 | -1.60 |
| EPS Diluted Continuous Ops | -6.87 | -3.30 | -3.59 | -3.56 | -1.62 |
| EBITDA(a) | $-7,722 | $-9,032 | $-7,355 | $-6,217 | $-6,846 |